BioCentury
ARTICLE | Company News

Drug Royalty, University of Michigan deal

July 16, 2007 7:00 AM UTC

Drug Royalty acquired the university's future royalties on the sales of FluMist intranasal influenza vaccine for up to $35 million based on undisclosed conditions. In January, FDA approved a refriger...